Combined Prostate-specific Antigen Density and Biopsy Features to Predict "Clinically Insignificant" Prostate Cancer

Urology

Volumn 72, Issue 1, 2008, Pages 143-147

  Loeb, Stacy ^a   Roehl, Kimberly A ^b   Thaxton, C Shad ^c   Catalona, William J ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 45849099462     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.11.009     Document Type: Article

References (11)

1. Khan M.A., Han M., Partin A.W., et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 62 (2003) 86-91 discussion 9186-92
2. American Cancer Society. Cancer facts and figures 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf Accessed May 5, 2007
3. Epstein J.I., Walsh P.C., Carmichael M., et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368-374
4. Miller D.C., Gruber S.B., Hollenbeck B.K., et al. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst 98 (2006) 1134-1141
5. Bastian P.J., Mangold L.A., Epstein J.I., et al. Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis. Cancer 101 (2004) 2001-2005
6. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977
7. Stamey T.A., Freiha F.S., McNeal J.E., et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71 (1993) 933-938
8. Humphrey P.A., and Vollmer R.T. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol 10 (1997) 326-333
9. Kattan M.W., Eastham J.A., Wheeler T.M., et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 170 (2003) 1792-1797
10. Anast J.W., Andriole G.L., Bismar T.A., et al. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?. Urology 64 (2004) 544-550
11. Miyake H., Sakai I., Harada K., et al. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease. Int J Urol 12 (2005) 270-274